LT - NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-RELATED DISORDERS, INCLUDING TREATING AND PREVENTING INFECTION BY MODULATING INNATE IMMUNITY
EN - NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-RELATED DISORDERS, INCLUDING TREATING AND PREVENTING INFECTION BY MODULATING INNATE IMMUNITY
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
(51) |
INT.CL. |
C12N 15/11 |
|
|
|
A61K 38/08 |
|
|
|
A61K 38/10 |
|
|
|
A61P 31/00 |
|
|
|
A61P 33/00 |
|
|
|
A61P 37/02 |
|
|
|
C07K 16/00 |
|
|
|
C12N 1/21 |
|
|
|
C12N 15/63 |
|
|
|
C12P 21/02 |
|
|
|
C12Q 1/37 |
|
Europos patentas
(11) |
Patento numeris |
2447367 |
(13) |
Dokumento rūšis |
T |
(96) |
Europos patento paraiškos numeris |
11182635.0 |
|
Europos patento paraiškos padavimo data |
2006-10-04 |
(97) |
Europos patento paraiškos paskelbimo data |
2012-05-02 |
(45) |
Paskelbimo apie Europos patento išdavimą data |
2018-12-05
|
(46) |
Apibrėžties vertimo paskelbimo data |
|
Prioriteto paraiškos
(30) |
Numeris |
Data |
Šalis |
|
722962 P |
2005-10-04
|
US |
|
722958 P |
2005-10-04
|
US |
|
722959 P |
2005-10-04
|
US |
Išradėjai
(72) |
Donini, Oreola, CA
Rozek, Annett, CA
Lentz, Shannon Wayne, CA
|
Savininkas
(73) |
Soligenix, Inc.,
29 Emmons Drive, Suite C-10, Princeton, NJ 08540,
US
|
Pavadinimas
(54) |
NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-RELATED DISORDERS, INCLUDING TREATING AND PREVENTING INFECTION BY MODULATING INNATE IMMUNITY |
|
NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-RELATED DISORDERS, INCLUDING TREATING AND PREVENTING INFECTION BY MODULATING INNATE IMMUNITY |